Manufacturing
Biological Prospects uses a single contract manufacturing facility to produce our nutraceutical ingredients. Our contract manufacturer is an active pharmaceutical ingredient (API) and dietary ingredient manufacturer that operates under current good manufacturing practices (GMPs; Pharmaceuticals 21 CFR 210&211; Nutraceuticals 21 CFR 111). Our contract manufacturer was audited by the United States Food and Drug Administration in the second quarter of 2011 and did not receive any 483 violations.
Intellectual Property
Biological Prospects uses a patent pending process to manufacture our premium stilbene ingredients. The company’s goal is to continue to develop innovative chemical processes for the synthesis of valuable therapeutic compounds.